{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:44:53Z","timestamp":1790793893971,"version":"4.1.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.pnpbp.2008.07.001","type":"journal-article","created":{"date-parts":[[2008,7,7]],"date-time":"2008-07-07T08:02:23Z","timestamp":1215417743000},"page":"1677-1681","source":"Crossref","is-referenced-by-count":180,"title":["Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia"],"prefix":"10.1016","volume":"32","author":[{"given":"Maur\u00edcio","family":"Kunz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarissa Severino","family":"Gama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Cristina","family":"Andreazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirian","family":"Salvador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keila Mendes","family":"Ceres\u00e9r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiano Alves","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo Silva","family":"Belmonte-de-Abreu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Berk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavio","family":"Kapczinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.pnpbp.2008.07.001_bib1","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/clinchem\/32.5.805","article-title":"Activities of superoxide dismutase and glutathione peroxidase in schizophrenic and manic-depressive patients","volume":"32","author":"Abdalla","year":"1986","journal-title":"Clin Chem"},{"issue":"5","key":"10.1016\/j.pnpbp.2008.07.001_bib2","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0278-5846(02)00220-8","article-title":"The indices of endogenous oxidative and antioxidative processes in plasma from schizophrenic patients. The possible role of oxidant\/antioxidant imbalance","volume":"26","author":"Akyol","year":"2002","journal-title":"Prog Neuro-psychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.07.001_bib3","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jpsychires.2006.07.013","article-title":"Serum S100B and antioxidant enzymes in bipolar patients","volume":"41","author":"Andreazza","year":"2007","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.pnpbp.2008.07.001_bib4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.psychres.2006.03.025","article-title":"DNA damage in bipolar disorder","volume":"153","author":"Andreazza","year":"2007","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.pnpbp.2008.07.001_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.jad.2008.04.013","article-title":"Oxidative stress markers in bipolar disorder: A meta-analysis","author":"Andreazza","year":"2008","journal-title":"J Affect Disord."},{"issue":"1","key":"10.1016\/j.pnpbp.2008.07.001_bib6","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0006-3223(02)01443-9","article-title":"Essential polyunsaturated fatty acid and lipid peroxide levels in never-medicated and medicated schizophrenia patients","volume":"53","author":"Arvindakshan","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.07.001_bib7","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1192\/bjp.175.2.154","article-title":"Using consensus OPCRIT diagnoses \u2014 an efficient procedure for best-estimate lifetime diagnoses","volume":"175","author":"Azevedo","year":"1999","journal-title":"Br J Psychiatry"},{"issue":"4","key":"10.1016\/j.pnpbp.2008.07.001_bib8","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1093\/schbul\/sbm064","article-title":"Searching for unique endophenotypes for schizophrenia and bipolar disorder within neural circuits and their molecular regulatory mechanisms","volume":"33","author":"Benes","year":"2007","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.pnpbp.2008.07.001_bib9","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/sj.mp.4001758","article-title":"The expression of proapoptosis genes is increased in bipolar disorder, but not in schizophrenia","volume":"11","author":"Benes","year":"2006","journal-title":"Mol Psychiatry"},{"issue":"7","key":"10.1016\/j.pnpbp.2008.07.001_bib65","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.tips.2008.05.001","article-title":"Glutathione: a novel treatment target in psychiatry","volume":"29","author":"Berk","year":"2008","journal-title":"Trends Pharmacol Sci"},{"issue":"3","key":"10.1016\/j.pnpbp.2008.07.001_bib11","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1046\/j.1471-4159.1999.0731127.x","article-title":"Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson's disease","volume":"73","author":"Berman","year":"1999","journal-title":"J Neurochem"},{"key":"10.1016\/j.pnpbp.2008.07.001_bib12","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0006-3223(00)00883-0","article-title":"Are schizophrenic and bipolar disorders related? A review of family and molecular studies","volume":"48","author":"Berrettini","year":"2000","journal-title":"Biol Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2008.07.001_bib13","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1093\/aje\/kwf029","article-title":"Factors associated with oxidative stress in human populations","volume":"156","author":"Block","year":"2002","journal-title":"Am J Epidemiol"},{"issue":"3","key":"10.1016\/j.pnpbp.2008.07.001_bib14","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1152\/physrev.1979.59.3.527","article-title":"Hydroperoxide metabolism in mammalian organs","volume":"59","author":"Chance","year":"1979","journal-title":"Physiol Rev"},{"issue":"2","key":"10.1016\/j.pnpbp.2008.07.001_bib15","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1523\/JNEUROSCI.3602-07.2008","article-title":"Unregulated cytosolic dopamine causes neurodegeneration associated with oxidative stress in mice","volume":"28","author":"Chen","year":"2008","journal-title":"J Neurosci"},{"issue":"5134","key":"10.1016\/j.pnpbp.2008.07.001_bib16","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1126\/science.7901908","article-title":"Oxidative stress, glutamate, and neurodegenerative disorders","volume":"262","author":"Coyle","year":"1993","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.pnpbp.2008.07.001_bib17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/schbul\/sbj033","article-title":"Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology","volume":"32","author":"Craddock","year":"2006","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.pnpbp.2008.07.001_bib18","series-title":"Structured Clinical Interview for DSM-IV (SCID-I)","author":"First","year":"1998"},{"key":"10.1016\/j.pnpbp.2008.07.001_bib19","first-page":"326","article-title":"Effects of lithium and valproate on amphetamine-induced oxidative stress generation in an animal model of mania","volume":"31","author":"Frey","year":"2006","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.pnpbp.2008.07.001_bib20","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.pnpbp.2006.06.011","article-title":"Increased oxidative stress and DNA damage in bipolar disorder: a twin-case report","volume":"31","author":"Frey","year":"2007","journal-title":"Prog Neuro-psychopharmacol Biol Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2008.07.001_bib21","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.pnpbp.2005.11.009","article-title":"Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in schizophrenia: a study of patients treated with haloperidol or clozapine","volume":"30","author":"Gama","year":"2006","journal-title":"Prog Neuro-psychopharmacol Biol Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2008.07.001_bib22","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.neulet.2007.04.001","article-title":"Serum levels of brain-derived neurotrophic factor in patients with schizophrenia and bipolar disorder","volume":"420","author":"Gama","year":"2007","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pnpbp.2008.07.001_bib23","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.neulet.2008.01.018","article-title":"Elevated serum thiobarbituric acid reactive substances in clinically symptomatic schizophrenic males","volume":"433","author":"Gama","year":"2008","journal-title":"Neurosci Lett"},{"issue":"3","key":"10.1016\/j.pnpbp.2008.07.001_bib24","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.pnpbp.2006.12.020","article-title":"Changes in nitric oxide level and superoxide dismutase activity during antimanic treatment","volume":"31","author":"Gergerlioglu","year":"2007","journal-title":"Prog Neuro-psychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.07.001_bib25","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.pnpbp.2006.09.012","article-title":"Assessment of malondialdehyde levels in schizophrenia: a meta-analysis and some methodological considerations","volume":"31","author":"Grignon","year":"2007","journal-title":"Prog Neuro-psychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.07.001_bib26","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.07.001_bib27","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1073\/pnas.93.5.1956","article-title":"Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections","volume":"93","author":"Hastings","year":"1996","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.pnpbp.2008.07.001_bib28","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/hmg\/ddi022","article-title":"Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis","volume":"14","author":"Iwamoto","year":"2005","journal-title":"Hum Mol Genet"},{"issue":"4","key":"10.1016\/j.pnpbp.2008.07.001_bib29","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.neubiorev.2007.10.005","article-title":"Allostatic load in bipolar disorder: implications for pathophysiology and treatment","volume":"32","author":"Kapczinski","year":"2008","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pnpbp.2008.07.001_bib30","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.biopsych.2003.12.012","article-title":"Mitochondrial complex I subunits expression is altered in schizophrenia: a postmortem Study","volume":"55","author":"Karry","year":"2004","journal-title":"Biol Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2008.07.001_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00023210-200721010-00001","article-title":"Mitochondrial dysfunction as the molecular basis of bipolar disorder: therapeutic implications","volume":"21","author":"Kato","year":"2007","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.pnpbp.2008.07.001_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0920-9964(01)00334-6","article-title":"Reduced erythrocyte membrane essential fatty acids and increased lipid peroxides in schizophrenia at the never-medicated first-episode of psychosis and after years of treatment with antipsychotics","volume":"58","author":"Khan","year":"2002","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2008.07.001_bib32","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1001\/archpsyc.61.3.300","article-title":"Molecular evidence for mitochondrial dysfunction in bipolar disorder","volume":"61","author":"Konradi","year":"2004","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.07.001_bib33","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/cbf.940","article-title":"Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder","volume":"20","author":"Kuloglu","year":"2002","journal-title":"Cell Biochem Funct"},{"issue":"1","key":"10.1016\/j.pnpbp.2008.07.001_bib34","first-page":"159","article-title":"Free radical involvement in neuropsychiatry illnesses","volume":"31","author":"Lohr","year":"1995","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.pnpbp.2008.07.001_bib35","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1399-5618.2006.00302.x","article-title":"Decrease in creatine kinase messenger RNA expression in the hippocampus and dorsolateral prefrontal cortex in bipolar disorder","volume":"8","author":"MacDonald","year":"2006","journal-title":"Bipolar Disord"},{"issue":"1","key":"10.1016\/j.pnpbp.2008.07.001_bib36","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.neulet.2007.05.016","article-title":"Oxidative stress parameters in unmedicated and treated bipolar subjects during initial manic episode: a possible role for lithium antioxidant effects","volume":"421","author":"Machado-Vieira","year":"2007","journal-title":"Neurosci Lett"},{"issue":"1","key":"10.1016\/j.pnpbp.2008.07.001_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0920-9964(95)00049-6","article-title":"Free radical pathology and antioxidant defense in schizophrenia: a review","volume":"19","author":"Mahadik","year":"1996","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2008.07.001_bib39","first-page":"3170","article-title":"The role of superoxide anion in the antioxidation of epinephrine and a simple assay for superoxide dismutase","volume":"217","author":"Mirsa","year":"1972","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pnpbp.2008.07.001_bib40","first-page":"1","article-title":"Oxidative stress in psychiatric disorders: evidence base and therapeutic implications","author":"Ng","year":"2008","journal-title":"Int J Neuropsychopharmacol"},{"issue":"1","key":"10.1016\/j.pnpbp.2008.07.001_bib41","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1152\/physrev.2000.80.1.315","article-title":"Mitochondria and neuronal survival","volume":"80","author":"Nicholls","year":"2000","journal-title":"Physiol Rev"},{"issue":"9","key":"10.1016\/j.pnpbp.2008.07.001_bib42","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s00702-005-0415-0","article-title":"Nitric oxide and MPP+-induced hydroxyl radical generation: a review","volume":"113","author":"Obata","year":"2002","journal-title":"J Neural Transm"},{"issue":"2","key":"10.1016\/j.pnpbp.2008.07.001_bib43","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/00004850-200403000-00006","article-title":"Antioxidant enzyme activities and oxidative stress in affective disorders","volume":"19","author":"Ozcan","year":"2004","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2008.07.001_bib44","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0022-3956(02)00048-1","article-title":"Differential effects of antipsychotics on expression of antioxidant enzymes and membrane lipid peroxidation in rat brain","volume":"37","author":"Parikh","year":"2003","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.pnpbp.2008.07.001_bib45","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0165-1781(03)00220-8","article-title":"Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients","volume":"121","author":"Ranjekar","year":"2003","journal-title":"Psychiatry Res"},{"issue":"4","key":"10.1016\/j.pnpbp.2008.07.001_bib46","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/gerona\/63.4.360","article-title":"Age-related correlation between antioxidant enzymes and DNA damage with smoking and body mass index","volume":"63","author":"Reddy Thavanati","year":"2008","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.pnpbp.2008.07.001_bib47","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1046\/j.1471-4159.2003.01898.x","article-title":"Mitochondrial apoptotic cell death and moderate superoxide generation upon selective activation of non-desensitizing AMPA receptors in hippocampal cultures","volume":"86","author":"Rego","year":"2003","journal-title":"J Neurochem"},{"issue":"1","key":"10.1016\/j.pnpbp.2008.07.001_bib48","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/15622970510029993","article-title":"Elevated serum nitric oxide and superoxide dismutase in euthymic bipolar patients: impact of past episodes","volume":"7","author":"Savas","year":"2006","journal-title":"World J Biol Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.pnpbp.2008.07.001_bib50","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jad.2007.08.006","article-title":"The course of nitric oxide and superoxide dismutase during treatment of bipolar depressive episode","volume":"107","author":"Selek","year":"2008","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pnpbp.2008.07.001_bib51","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.arr.2004.05.002","article-title":"Reactive oxygen species and synaptic plasticity in the aging hippocampus","volume":"3","author":"Serrano","year":"2004","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.pnpbp.2008.07.001_bib52","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.biopsych.2005.04.052","article-title":"Chronic treatment with mood stabilizers lithium and valproate prevents excitotoxicity by inhibiting oxidative stress in rat cerebral cortical cells","volume":"58","author":"Shao","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.07.001_bib53","first-page":"189","article-title":"Downregulation in components of the mitochondrial electron transport chain in the postmortem frontal cortex of subjects with bipolar disorder","volume":"31","author":"Sun","year":"2006","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.pnpbp.2008.07.001_bib54","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.pneurobio.2004.02.001","article-title":"Astrocyte apoptosis: implications for neuroprotection","volume":"72","author":"Takuma","year":"2004","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.pnpbp.2008.07.001_bib55","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1089-8603(02)00126-X","article-title":"Long-term effects of newer antipsychotic drugs on neuronal nitric oxide synthase in rat brain","volume":"7","author":"Tarazi","year":"2002","journal-title":"Nitric Oxide"},{"issue":"4","key":"10.1016\/j.pnpbp.2008.07.001_bib56","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/aje\/154.4.348","article-title":"Correlates of markers of oxidative status in the general population","volume":"154","author":"Trevisan","year":"2001","journal-title":"Am J Epidemiol"},{"issue":"2","key":"10.1016\/j.pnpbp.2008.07.001_bib57","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1021\/tx700411g","article-title":"Bulky DNA lesions induced by reactive oxygen species","volume":"21","author":"Wang","year":"2008","journal-title":"Chem Res Toxicol"},{"issue":"2\u20133","key":"10.1016\/j.pnpbp.2008.07.001_bib58","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.schres.2005.04.016","article-title":"Increased nicotine and cotinine levels in smokers with schizophrenia and schizoaffective disorder is not a metabolic effect","volume":"79","author":"Williams","year":"2005","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2008.07.001_bib59","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1042\/bj0990667","article-title":"Mechanism of lipid peroxide formation in animal tissues","volume":"99","author":"Wills","year":"1966","journal-title":"Biochem J"},{"issue":"1","key":"10.1016\/j.pnpbp.2008.07.001_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0920-9964(98)00030-9","article-title":"Reduced status of plasma total antioxidant capacity in schizophrenia","volume":"32","author":"Yao","year":"1998","journal-title":"Schizophr Res."},{"issue":"5","key":"10.1016\/j.pnpbp.2008.07.001_bib61","first-page":"40","article-title":"Atypical antipsychotics in bipolar depression: potential mechanisms of action","volume":"66","author":"Yatham","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.07.001_bib62","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pnpbp.2008.07.001_bib63","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1093\/brain\/awh259","article-title":"Mitochondrial disorders","volume":"127","author":"Zeviani","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.pnpbp.2008.07.001_bib64","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00406-004-0456-7","article-title":"Increased oxidative stress and altered activities of erythrocyte free radical scavenging enzymes in autism","volume":"254","author":"Zoroglu","year":"2004","journal-title":"Eur Arch Psychiatry Clin Neurosci"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027858460800198X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027858460800198X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T21:30:22Z","timestamp":1588800622000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027858460800198X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":63,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S027858460800198X"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2008.07.001","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}